A Lilly study showed Mounjaro resulted in a lower risk of heart attacks and strokes in patients with diabetes compared with ...

Between 900,000 and 1.4 million Canadians use a GLP-1 drug like Ozempic to manage weight loss and Type 2 diabetes, according to a March 2024 survey by Dalhousie University’s Agri-Food Analytics Lab.

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting health officials to launch a new study into side effects. Some cases of ...